Sign in

CIK 0001468929

  • Emerging growth company

NEXGEL, INC.

Sign in to watch
Ticker
NXGL
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264042544
Phone
+1 215-702-8550
Business address
2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
Former names
NEXGEL, INC., AquaMed Technologies, Inc.

Securities

  • NXGL Common Stock Nasdaq
  • NXGLW Warrant Nasdaq
  1. 4 Planned sale Director sold 3,000 shares at $3.37 ($10,097)
  2. 4 Planned sale Chief Executive Officer sold 4,000 shares at $3.96 ($15,828)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Planned sale Director sold 3,000 shares at $4.64 ($13,935)
  5. 4 Open-market buy Director bought 1,818 shares at $2.75 ($5,000)
  6. 4 Open-market buy Chief Executive Officer bought 3,636 shares at $2.75 ($9,999)
  7. 4 Open-market buy Director bought 3,636 shares at $2.75 ($9,999)
  8. 4 Open-market buy Chief Financial Officer bought 17,500 shares at $2.75 ($48,125)
  9. 4 Open-market buy Director bought 9,090 shares at $2.75 ($24,998)
  10. 4 Open-market buy Director bought 3,636 shares at $2.75 ($9,999)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Director bought 10,000 shares at $2.50 ($25,000)
  16. 4 Open-market buy Director bought 10,000 shares at $2.50 ($25,000)
  17. 4 Open-market buy Director bought 10,000 shares at $2.50 ($25,000)
  18. 4 Open-market buy Director bought 10,000 shares at $2.50 ($25,000)
  19. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $2.50 ($25,000)
  20. 4 Open-market buy Director bought 23,697 shares at $2.11 ($50,001)

Page 3 of 6 · 115 filings